Literature DB >> 26050122

Epigenetics in acute kidney injury.

Jinhua Tang1, Shougang Zhuang.   

Abstract

PURPOSE OF REVIEW: Recent advances in epigenetics indicate the involvement of several epigenetic modifications in the pathogenesis of acute kidney injury (AKI). The purpose of this review is to summarize our understanding of recent advances in the epigenetic regulation of AKI and provide mechanistic insight into the role of acetylation, methylation, and microRNA expression in the pathological processes of AKI. RECENT
FINDINGS: Enhancement of protein acetylation by pharmacological inhibition of histone deacetylases leads to more severe tubular injury and impairment of renal structural and functional recovery. The changes in promoter DNA methylation occur in the kidney with ischemia/reperfusion. microRNA expression is associated with regulation of both renal injury and regeneration after AKI.
SUMMARY: Recent studies on epigenetic regulation indicate that acetylation, methylation, and microRNA expression are critically implicated in the pathogenesis of AKI. Strategies targeting epigenetic processes may hold a therapeutic potential for patients with AKI.

Entities:  

Mesh:

Year:  2015        PMID: 26050122      PMCID: PMC4559861          DOI: 10.1097/MNH.0000000000000140

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  67 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Ischemic epigenetics and the transplanted kidney.

Authors:  J R Pratt; M D Parker; L J Affleck; C Corps; L Hostert; E Michalak; J P A Lodge
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

Review 3.  Anticancer activities of histone deacetylase inhibitors.

Authors:  Jessica E Bolden; Melissa J Peart; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

4.  Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation.

Authors:  T K Mehta; M O Hoque; R Ugarte; M H Rahman; E Kraus; R Montgomery; K Melancon; D Sidransky; H Rabb
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

Review 5.  Gene silencing by microRNAs: contributions of translational repression and mRNA decay.

Authors:  Eric Huntzinger; Elisa Izaurralde
Journal:  Nat Rev Genet       Date:  2011-02       Impact factor: 53.242

6.  Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins.

Authors:  Sandra Villanueva; Carlos Céspedes; Carlos P Vio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-11-10       Impact factor: 3.619

7.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells.

Authors:  Amaia Lujambio; Santiago Ropero; Esteban Ballestar; Mario F Fraga; Celia Cerrato; Fernando Setién; Sara Casado; Ana Suarez-Gauthier; Montserrat Sanchez-Cespedes; Anna Git; Anna Gitt; Inmaculada Spiteri; Partha P Das; Carlos Caldas; Eric Miska; Manel Esteller
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.

Authors:  Bodo Brueckner; Carlo Stresemann; Ruprecht Kuner; Cora Mund; Tanja Musch; Michael Meister; Holger Sültmann; Frank Lyko
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

9.  Altering a histone H3K4 methylation pathway in glomerular podocytes promotes a chronic disease phenotype.

Authors:  Gaelle M Lefevre; Sanjeevkumar R Patel; Doyeob Kim; Lino Tessarollo; Gregory R Dressler
Journal:  PLoS Genet       Date:  2010-10-28       Impact factor: 5.917

Review 10.  Epigenetics and microRNAs.

Authors:  Jody C Chuang; Peter A Jones
Journal:  Pediatr Res       Date:  2007-05       Impact factor: 3.756

View more
  26 in total

Review 1.  Renoprotective approaches and strategies in acute kidney injury.

Authors:  Yuan Yang; Meifang Song; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Pharmacol Ther       Date:  2016-04-22       Impact factor: 12.310

Review 2.  Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases.

Authors:  Weihuang Zhang; Xiaoyu Li; Shujun Wang; Yanse Chen; Huafeng Liu
Journal:  Cell Death Discov       Date:  2020-05-01

3.  A clinically relevant murine model unmasks a "two-hit" mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant.

Authors:  Zheng Zhang; Longhui Qiu; Shixian Yan; Jiao-Jing Wang; Paul M Thomas; Manoj Kandpal; Lihui Zhao; Andre Iovane; Xue-Feng Liu; Edward B Thorp; Qing Chen; Mary Hummel; Yashpal S Kanwar; Michael M Abecassis
Journal:  Am J Transplant       Date:  2019-05-14       Impact factor: 8.086

Review 4.  Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Authors:  Grazia Maria Virzì; Anna Clementi; Alessandra Brocca; Massimo de Cal; Claudio Ronco
Journal:  J Nephrol       Date:  2017-08-05       Impact factor: 3.902

5.  Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

Authors:  Yingfeng Shi; Liuqing Xu; Jinhua Tang; Lu Fang; Shuchen Ma; Xiaoyan Ma; Jing Nie; Xiaoling Pi; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

6.  Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.

Authors:  Yunhe Zhang; Jianan Zou; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2020-04-12       Impact factor: 5.191

7.  Methylation in pericytes after acute injury promotes chronic kidney disease.

Authors:  Yu-Hsiang Chou; Szu-Yu Pan; Yu-Han Shao; Hong-Mou Shih; Shi-Yao Wei; Chun-Fu Lai; Wen-Chih Chiang; Claudia Schrimpf; Kai-Chien Yang; Liang-Chuan Lai; Yung-Ming Chen; Tzong-Shinn Chu; Shuei-Liong Lin
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

8.  Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.

Authors:  Xingying Chen; Chao Yu; Xiying Hou; Jialu Li; Tingting Li; Andong Qiu; Na Liu; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-26

9.  Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.

Authors:  Wei Zhang; Yinjie Guan; George Bayliss; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-05

Review 10.  Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury).

Authors:  Alireza Raji-Amirhasani; Mohammad Khaksari; Fatemeh Darvishzadeh Mahani; Zahra Hajializadeh
Journal:  Clin Exp Nephrol       Date:  2021-03-29       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.